The DOPPS study results showed a trend toward increased infection-related mortality in patients receiving IV iron at doses >300 mg/month, but this was not statistically significant [ 17 ].
← all excerpts
Safety of High-Dose Intravenous Iron in Hemodialysis Patients: Results from the National Health Insurance Service (2019-2020) in South Korea.
1
—
—